CASE
Modular Biotech Package for Investor Interest
A very early-stage biotech company with limited funding needed to build a solid data package to attract investor interest. While initial protein expression had been done at a university, a properly documented cell line and scalable process were essential for moving forward.
Our solution
Bioneer is delivering a modular, phased approach tailored to the company’s evolving needs and budget. Early efforts focused on expression testing and low-cost purification to support Gen 1 product testing. After securing a grant, Bioneer is expanding support to include candidate selection, cell line development, and scalable process optimization for tech transfer.
Key Results:
- Generated critical data to support investor outreach
- Secured grant funding for next development phase
- Delivering a documented cell line and scalable process for tech transfer
